Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: long-lasting (12), long-standing (22)

MP000 028 Cellular pathology user handbook v24

Description: University Hospital Southampton NHS Foundation Trust PATHOLOGY DIRECTORATE Cellular Pathology (Management) MP 000 028 Revision 24 Page
Url: /Media/UHS-website-2019/Docs/Services/Pathology/Cell-path/MP000-028-Cellular-pathology-user-handbook-v24.pdf

Asciminib

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Asciminib Regimen • Asciminib Indication • Patients with chronic phase Philad
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Asciminib.pdf

Having a neurosurgical or spinal operation in the prone position - patient information

Description: This factsheet contains information about having a neurosurgical or spinal operation in the prone position.
Url: /Media/UHS-website-2019/Patientinformation/Surgery/Having-a-neurosurgical-or-spinal-operation-in-the-prone-position-3039-PIL.pdf

NilotinibChronic

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (chronic phase) Regimen • CML – Nilotinib (chronic phase) Indicatio
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibChronic.pdf

NilotinibAccelerated

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (accelerated phase) Regimen • CML – Nilotinib (accelerated phase) I
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibAccelerated.pdf

Bosutinib

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Bosutinib Regimen • Bosutinib Indication • As an option for the treatment of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Bosutinib.pdf

Impaired glucose tolerance in cystic fibrosis - patient information

Description: This factsheet is about impaired glucose tolerance (IGT) in people with cystic fibrosis (CF).
Url: /Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Impaired-glucose-tolerance-in-cystic-fibrosis-2636-PIL.pdf

Dr Kristin Veighey, associate director and academic career development lead for medical clinical research fellows

Description: Southampton Academy of Research Auto Generated Title Dr Veighey aims to identify and promote research training opportunities for current and future
Url: /ClinicalResearchinSouthampton/Our-people/Education-and-training-people/Dr-Kristin-Veighey-associate-director-and-academic-career-development-lead-for-medical-clinical-research-fellows.aspx

Radioactive iodine treatment for thyroid cancer - patient information

Description: This factsheet explains what radioactive iodine (RAI) treatment for thyroid cancer is and what the treatment involves, so you know what
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Radioactive-iodine-treatment-for-thyroid-cancer-3871-PIL.pdf

Cemiplimab

Description: Chemotherapy Protocol SKIN CANCER Cemiplimab (350mg) Regimen  Skin – Cemiplimab (350mg) Indication  Metastatic or locally adva
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Cemiplimab.pdf

11 to 20 of 164

Previous 1 2 3 4 5 … Next